The Procter & Gamble Company
Manufactures and sells household and personal care products globally under brands including Tide, Gillette, Pampers, Olay, and Crest.
As of Oct 15, 2026
Summary
The Procter & Gamble Company is a consumer staples giant producing household and personal care products sold worldwide. The stock trades with a neutral technical lean at $156.53, having gained 6.7% over the past month and 9.3% over the past year. Its market capitalisation stands at $356 billion.
Price history
As of Oct 14, 2026
Performance
+0.34%
+5.89%
+6.72%
+4.09%
+11.66%
+9.25%
As of Oct 14, 2026
Technical indicators
- 71.3Bearish
- 0.95Bullish
- 50: 146.42 · 200: 146.58
- $146.48 / $156.63
Technical Bias
Procter & Gamble's technical setup is evenly split: RSI is overbought at 71.3, MACD momentum is positive, and the 50 and 200-day moving averages are nearly flat. This derived technical read suggests neutral footing, with the stock trading just below resistance at $156.63 and well above support at $146.48.
A transparent read of the indicators below — not a prediction or recommendation.
As of Oct 14, 2026
Fundamentals
- $356B
- 23.14
- $6.62
- 18.44%
- +1.5%
- $15.1B
- 0.38
- $134.62 – $164.77
- 2.88%
- Jul 24, 2026
- Oct 22, 2026 (6 days)
As of Oct 16, 2026
Upcoming catalysts
- Earnings report
As of Oct 16, 2026
Latest news
As of Oct 16, 2026
MonkeyTrade's Take on The Procter & Gamble Company
Short-term outlook
Procter & Gamble's short-term setup leans bullish, with MACD confirming the strength behind the recent 6.7% monthly climb, though an RSI of 71.3 signals the stock is overbought and due a pause or pullback. The flat 50- and 200-day averages near $146.50 mark key support, while $156.63 resistance is the level to watch for continued upside. With earnings not due until October 2026, there's no near-term catalyst to disrupt this technical picture.
Medium-term outlook
Procter & Gamble's numbers describe a steady, cash-generative defensive name rather than a growth story: revenue growth of just 1.5% sits alongside a healthy 18.4% profit margin and a 2.9% dividend yield, while the 23.14 P/E suggests the market already pays up for that stability. With the technical lean neutral, the medium-term case rests on income and resilience, not momentum. A clear pickup in revenue growth would be the development that shifts this view.
Key risks
- Revenue growth of just +1.5% year on year is modest for a company of this size, raising questions about how much organic momentum P&G has left.
- The stock trading below its historical average and reports suggesting it may be undervalued point to some uncertainty in how the market is currently pricing its growth prospects.
- With a beta of 0.38, P&G tends to move less than the broader market, which can mean more muted upside if conditions turn favourable for consumer stocks.
- A price-to-earnings ratio of 23.14 against slow revenue growth means the stock isn't cheap relative to its current pace of expansion, which could weigh on sentiment if growth doesn't pick up.
About The Procter & Gamble Company
Procter & Gamble is a US consumer defensive giant listed on the NYSE under the ticker PG, operating in the household and personal products industry. With a market capitalisation of $356 billion, it ranks among the largest companies in its sector, reflecting its broad portfolio of everyday household and personal care brands and its established position in markets that tend to see steady demand regardless of the economic cycle.
PG's key figures point to a mature, income-oriented profile. A price-to-earnings ratio of 23.14 shows how the market currently values its earnings, while a dividend yield of +2.9% highlights its track record of returning cash to shareholders. Together, these figures reflect a business built around consistency and shareholder returns rather than rapid growth, characteristic of established names in the consumer defensive space.
How to trade The Procter & Gamble Company
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.